SCHEMBL12265754

SCHEMBL12265754

C=C(C)C1CCC2(C)CC(=O)CC(C)C2(C)C1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18031735 1.00 CYP2C19 (0.42) CYP2C19
SCHEMBL13588603 0.84 CYP2C19 (0.41) CYP2C19
SCHEMBL13683367 0.81 CYP2C19 (0.39) CYP2C19
SCHEMBL24968299 0.77 CYP2C19 (0.36) CYP2C19
SCHEMBL23740763 0.74 CYP2C19 (0.35) CYP2C19
SCHEMBL23713628 0.73 CYP2C19 (0.35) CYP2C19
SCHEMBL26099557 0.73 CYP2C19 (0.33) CYP2C19
SCHEMBL13588477 0.71 CYP2C19 (0.40) CYP2C19
SCHEMBL27207751 0.71 CYP2C19 (0.40) CYP2C19
SCHEMBL26189394 0.71 CYP2C19 (0.40) CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139806-A1 SELENIDE DERIVATIVES OF FRAGRANCE COMPOUNDS SYMRISE AG (DE) 2023-05-04 US disclosed
WO-2023067063-A1 IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS FIRMENICH SA (CH) 2023-04-27 WO disclosed
US-20230024269-A1 Pro-Perfume Compositions FIRMENICH SA (CH) 2023-01-26 US disclosed
US-20230020871-A1 Soap Composition FIRMENICH SA (CH) 2023-01-19 US disclosed
WO-2023275056-A1 TEXTILE ARTICLES FOR TUMBLE-DRYING FIRMENICH SA (CH) 2023-01-05 WO disclosed
WO-2022117613-A1 DRY SHAMPOO COMPOSITION FIRMENICH SA (CH) 2022-06-09 WO disclosed
WO-2022084437-A1 IMPROVED FRESHNESS IMPARTING COMPOSITIONS FIRMENICH SA (CH) 2022-04-28 WO disclosed
US-20210395654-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE PERFUMING MOLECULES FIRMENICH SA (CH) 2021-12-23 US disclosed
US-11155772-B2 Compounds for a controlled release of active perfuming molecules FIRMENICH SA (CH) 2021-10-26 US disclosed
WO-2021123144-A1 PRO-PERFUME COMPOSITIONS FIRMENICH SA (CH) 2021-06-24 WO disclosed
US-20100098649-A1 POLYMER CONJUGATES FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA 2010-04-22 US disclosed
US-20100098649-A1 POLYMER CONJUGATES FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA 2010-04-22 US disclosed
US-7589055-B2 Compounds for a controlled release of active molecules FIRMENICH SA (CH) 2009-09-15 US disclosed
US-20090181878-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA 2009-07-16 US disclosed
US-20090181878-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA 2009-07-16 US disclosed
US-20080279799-A1 Amphiphilic Co-Polymer Conjugates for a Controlled Release of Active Molecules FIRMENICH SA (CH) 2008-11-13 US disclosed
US-20080279799-A1 Amphiphilic Co-Polymer Conjugates for a Controlled Release of Active Molecules FIRMENICH SA (CH) 2008-11-13 US disclosed
EP-1460994-B1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH & CIE (CH) 2008-10-01 EP disclosed
WO-2008044178-A1 POLYMER CONJUGATES FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA (CH) 2008-04-17 WO disclosed
WO-2007007216-A2 AMPHIPHILIC CO-POLYMER CONJUGATES FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES FIRMENICH SA (CH) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11155772-B2 Compounds for a controlled release of active perfuming molecules ACLY, CBS, PIR CYP2C19 290/4885
US-20080279799-A1 Amphiphilic Co-Polymer Conjugates for a Controlled Release of Active Molecules ACLY, CETP, TTPA CYP2C19 619/4885
US-20210395654-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE PERFUMING MOLECULES ACLY, CBS, TRPA1 CYP2C19 506/4885
US-20090181878-A1 COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES ACLY, PTGES, PPOX CYP2C19 347/4885
US-20100098649-A1 POLYMER CONJUGATES FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES ACLY, PPOX, PFAS CYP2C19 409/4885
US-20230139806-A1 SELENIDE DERIVATIVES OF FRAGRANCE COMPOUNDS SELENOI, FASN, EBP CYP2C19 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.